Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have RNA polymerase II complex binding activity. Predicted to be involved in mRNA 3'-end processing. Predicted to localize to RNA polymerase II, holoenzyme. Is expressed in several structures, including blastocyst; early embryo; and extraembryonic component. Orthologous to human RPRD2 (regulation of nuclear pre-mRNA domain containing 2).